EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Freezing ability of two slow permeating cryoprotectants on rooster semen diluted with tris egg-yolk juice extender

Adedeji Suleimon Balogun, Raman Narang, Ranjna S Cheema, Prem Prakash Dubey, Shakti kant Dash, Neeraj Kashyap, Saroj Kumar Sahoo

Letters In Animal Biology · 2021

DOI: 10.62310/liab.v1i2.61 ↗
AbstractBibliografische Angaben

Abstract

Cryo-damage reduction with slow permeating cryoprotectants has been identified as a promising approach for poultry semen preservation. This study was conducted to evaluate the efficacy of dimethylformamide (DMF), methylacetamide (MA), and their mixtures (DMF+MA) in the cryopreservation of rooster semen extended with tris quail egg-yolk (TEY) extender supplemented with orange or tomato juice. The extender was prepared by adding 25% of egg-yolk in tris buffer. 18% & 13% (v/v) DMF, MA, and (DMF+MA) were added to the extender constituting six treatments. Semen was collected from fifteen roosters of 35weeks of age by backstroke massage of mid abdomen followed by semen pooling. Pooled semen was divided into six fractions and two steps dilution was done. Extended semen samples were subjected to cryopreservation procedures and finally stored at -196 oC. After 48h, semen samples were thawed at 5oC and evaluated for motility, viability, membrane integrity, and acrosome integrity. Effects of juices on TEY extended semen were further evaluated with 13% and 18% (DMF+MA). 15% of orange (O) and tomato (T) juices were supplemented to TEY extender. Same dilution, freezing and evaluation procedures were observed. Finally, fertility trials were conducted on the best treatments. The results revealed that 13% and 18% (DMF+MA) had significantly (P

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →